Correlation Between CVS Health and Crispr Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CVS Health and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CVS Health and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CVS Health Corp and Crispr Therapeutics AG, you can compare the effects of market volatilities on CVS Health and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CVS Health with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CVS Health and Crispr Therapeutics.

Diversification Opportunities for CVS Health and Crispr Therapeutics

  Correlation Coefficient

Weak diversification

The 3 months correlation between CVS Health and Crispr is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding CVS Health Corp and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and CVS Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CVS Health Corp are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of CVS Health i.e., CVS Health and Crispr Therapeutics go up and down completely randomly.

Pair Corralation between CVS Health and Crispr Therapeutics

Considering the 90-day investment horizon CVS Health Corp is expected to generate 0.49 times more return on investment than Crispr Therapeutics. However, CVS Health Corp is 2.03 times less risky than Crispr Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about -0.04 per unit of risk. If you would invest  9,814  in CVS Health Corp on September 4, 2022 and sell it today you would earn a total of  444.00  from holding CVS Health Corp or generate 4.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
ValuesDaily Returns

CVS Health Corp  vs.  Crispr Therapeutics AG

 Performance (%) 
CVS Health Corp 
CVS Health Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in CVS Health Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, CVS Health is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

CVS Health Price Channel

Crispr Therapeutics 
Crispr Performance
0 of 100
Over the last 90 days Crispr Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm insiders.

Crispr Price Channel

CVS Health and Crispr Therapeutics Volatility Contrast

   Predicted Return Density   

Pair Trading with CVS Health and Crispr Therapeutics

The main advantage of trading using opposite CVS Health and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CVS Health position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.
CVS Health vs. ABIOMED
CVS Health vs. Abbott Laboratories
CVS Health vs. Adicet Bio
CVS Health vs. Aethlon Medical
The idea behind CVS Health Corp and Crispr Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Crispr Therapeutics vs. Agilent Technologies
Crispr Therapeutics vs. Aurora Cannabis
Crispr Therapeutics vs. Acer Therapeutics
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
CEO Directory
Screen CEOs from public companies around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings